DPP IV Inhibition Facilitates Healing of Chronic Foot Ulcers in Type 2 Diabetes
Status:
Completed
Trial end date:
2016-01-01
Target enrollment:
Participant gender:
Summary
A randomized versus placebo trial designed to evaluate the clinical and humoral effects of 4
months of vildagliptin on healing of chronic ulcers in type 2 diabetes.
Phase:
Phase 4
Details
Lead Sponsor:
Second University of Naples University of Campania "Luigi Vanvitelli"